paula's choice 25 vitamin c + glutathione clinical serum 25% Glutathione + GAP technology (glutathione amino acid precursors) work to minimise irritation while amping up antioxidant protection and ingredient stability Paula's Choice - 25% Vitamin

Additional IV sedation packages are available at an additional cost

Data processing of metabolite-treatment untargeted metabolomics The metabolite annotation steps followed previous publication 21

Quinoa secondary metabolites and their biological activities or functions

Disclosure of interest: Isra Hatab: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2260 - ESOC25-1519 OUTCOMES PREDICTORS IN CANCER PATIENTS WITH LARGE VESSEL OCCLUSION STROKE UNDERGOING MECHANICAL THROMBECTOMY Carlota Villar Rodriguez 1,2 , Diego Villagran Sancho 1,2 , Luis Manzano-Hernndez 1,2 , Blanca Pardo-Galiana 1,2 , Leire Ainz-Gmez 1,2 , Pablo Baena Palomino 1,2 , Juan Antonio Cabezas Rodriguez 1,2 , Manuel Medina-Rodriguez 1,2 , Andrs Hermosn-Gmez 1,2 , Alejandro Gonzalez Garcia 2,3 , Marta Aguilar 2,3 , Asier de Albniga-Chindurza 2,3 , Francisco Moniche 1,2 , Elena Zapata Arriaza 2,3 1 Virgen del Rocio, University Hospital

Innovative approaches using nanoparticles containing STING agonists can reduce immunosuppressive cells in the TME

Schatz SB, Jngst C, Keitel-Anselmo V, Kubitz R, Becker C, Gerner P, Pfister ED, Goldschmidt I, Junge N, Wenning D, et al